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INTRODUCTION
Chronic periodontitis is an inflammatory disease initiated by 
the host immune response to dysbiotic biofilm in tissues sur-
rounding the teeth. Progression is characterized by ulceration 
of gingival epithelium, loss of periodontal ligament attach-
ment to the tooth surface, and destruction of the alveolar bone. 
Bleeding of ulcerated epithelium gives rise to bacterial inva-
sion of connective tissue and recurrent transient bacteremia 
with higher circulating levels of proinflammatory and pro-
thrombotic markers.1,2 The disease is associated with systemic 
chronic inflammatory disorders including type II diabetes, 
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metabolic syndrome, atherosclerosis, and cardiovascular dis-
ease.3–8 Chronic periodontitis has public health significance 
as the major cause of tooth loss.9 In 2009–2010 prevalence of 
severe chronic periodontitis in the US population aged 30 y or 
older was 8.5%,10 based on the case classification jointly devel-
oped by the Centers for Disease Control and Prevention and the 
American Academy of Periodontology (CDC-AAP).11
Sleep disordered breathing (SDB) encompasses a continuum 
of upper airway obstructive abnormalities ranging from pri-
mary snoring to more severe forms such as obstructive sleep 
apnea (OSA). Moderate to severe OSA is causally implicated 
in the development of hypertension and, like periodontitis, is 
strongly associated with cardiovascular disease.
Several studies point to the comorbidity of these two dis-
eases, but their evidence is limited by weaknesses in study 
design, measurement imprecision and small sample size.12–16 
Nonetheless, the relationship has biological plausibility 
through at least three potential mechanisms. One mechanism 
is dry mouth due to oral breathing (extrinsic cause) or prescrip-
tion medications (intrinsic cause). It is common for adults with 
SDB to breathe through their mouth and many patients report 
morning xerostomia, i.e., the subjective perception of dry 
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mouth. During oral breathing, gravity pulls the tongue back-
ward, restricting oropharyngeal region volume, increasing 
upper airway resistance17 and markedly increasing SDB se-
verity. Dry mouth may reduce the effectiveness of bacterial 
clearance of the oral tissues, leading to greater colonization 
of periodontal microbiota. One of the few studies to examine 
the periodontal consequences of extrinsic xerostomia studied 
2,077 healthy young adults, finding greater accumulation of 
biofilm and significantly more bleeding of gingival tissue on 
probing—two clinical signs of periodontal disease—among 
the 8.8% with xerostomia.18
A second potential mechanism linking SDB and periodon-
titis is oxidative stress. Even minor respiratory events are 
sufficient to disturb oxidative homeostasis and induce re-
lease of excess reactive oxygen species. Oxidative stress is a 
recognized feature of OSA19 and heightened oxidative stress 
in already inflamed periodontal tissues could augment the 
breakdown of periodontal attachment. Moreover, individuals 
with periodontitis have a decreased antioxidant capacity both 
locally and systemically20,21 to counter the harmful effects of 
oxidative stress. Periodontitis itself induces oxidative stress 
as a consequence of the release of excess proteolytic enzymes 
in an aberrant host inflammatory response to the bacterial 
challenge.22
A third potential mechanism is systemic inflammation. Both 
periodontitis and SDB involve local inflammation in the oral 
cavity and upper airway region. In addition, both involve sys-
temic inflammatory processes measurable as elevated levels 
of proteins such as C-reactive protein.23–25 Because high-sensi-
tivity CRP (hs-CRP) is a biomarker of systemic inflammation 
and is associated with SDB25 and periodontitis,24,26 it make play 
a role in the SDB and periodontitis relationship.
This study sought to build on previous investigations of this 
relationship in a large, well-designed population-based cohort 
of Hispanic/Latino adults using objective measures of SDB 
and examiner-verified periodontitis. Periodontitis is highly 
prevalent in this population relative to other racial/ethnic 
groups. Nationally representative data from NHANES 2009–
2010 estimate severe periodontitis prevalence is 6.3% among 
non-Hispanic whites, 13.2% among non-Hispanic Blacks, and 
17.3% among Mexican Americans.10 The primary aim of this 
cross-sectional analysis was to estimate the strength of asso-
ciation between SDB and chronic periodontitis across a range 
of SDB severities. The secondary aim was to investigate C-
reactive protein in this relationship. We hypothesized that a 
positive relationship between SDB and chronic periodontitis 
might be explained by elevated C-reactive protein levels.
METHODS
Study Population and Recruitment
The Hispanic/Latino Community Health Study/Study of La-
tinos (HCHS/SOL) is a multisite, population-based prospective 
cohort study designed to evaluate disease burden and health risk 
factors in the diverse, rapidly growing Hispanic/Latino popu-
lation. Details of the study design27 and sampling methods28 
have been described. In summary, sampling used a two-stage 
area household probability design. Screened individuals who 
self-identified as Hispanic or Latino were recruited from a 
random sample of households in neighboring census tracts of 
four cities with large Hispanic/Latino populations (Bronx, NY; 
Chicago, IL; Miami, FL; and San Diego, CA). The major heri-
tage groups were Mexican (n = 6,471), Puerto Rican (n = 2,728), 
Cuban (n = 2,348), Central American (n = 1,730), Dominican 
(n = 1,460), and South American (n = 1,068).
Sample weights were adjusted for nonresponse and were 
calibrated to the 2010 US Census for age, sex, and Hispanic 
background, so that estimates were generalizable to census 
tracts sampled in these four urban communities. Between 
2008 and 2011 approximately 4,000 people aged 18–74 y at the 
time of screening were recruited from each study site to yield 
a final sample size of 16,415 individuals. This study was ap-
proved by the Institutional Review Boards at each field center 
where all subjects gave written consent.
Interviews, Clinical Examination, and Laboratory Procedures
Questionnaires obtained information about demographic 
characteristics and cigarette smoking. Height was measured 
to the nearest centimeter and body weight, measured with 
the Tanita analyzer (Tanita Corp. of America, Skokie, IL), to 
the nearest 0.1 kg. Blood samples, including plasma glucose 
(fasting and after a 2-h oral glucose load) were collected ac-
cording to standardized protocols. Following a ≥ 8 h fast, all 
participants had a 2-h oral glucose tolerance test (OGTT) ex-
cept those with fasting plasma glucose (FPG) > 150 mg/dL 
and in whom diabetes had been previously diagnosed. Dia-
betes was defined as either FPG ≥ 126 mg/dL (7 mmol/L), 2-h 
OGTT ≥ 200 mg/dL (11.2 mmol/L), glycosylated hemoglobin 
(A1C) level ≥ 6.5% (48 mmol/mol), or use of hypoglycemic 
agents according to scanned/transcribed antidiabetic medica-
tions. Participants with glucose levels elevated above normal, 
but not meeting criteria for diabetes, were classified as pre-
diabetic based on impaired fasting glucose (IFG) or impaired 
glucose tolerance (IGT) using the following criteria. IFG was 
defined as FPG of 100–125 mg/dL (5.6–5.9 mmol/L). IGT was 
defined as 2-h plasma glucose (2-h PG) on the 75-g OGTT of 
140–199 mg/dL (7.8–11.0 mmol/L). High-sensitivity C-reactive 
protein was measured in serum on a Roche Modular P Chem-
istry Analyzer (Roche Diagnostics Corporation, Indianapolis, 
IN) using an immunoturbidimetric method (Roche Diagnos-
tics Corporation).
Periodontitis Assessment and Classification
Prior to the periodontal assessment, dentists assisted by 
trained recorders performed a count of remaining teeth.
Edentulous participants, i.e., those with no remaining teeth, 
and individuals requiring prophylactic antibiotic coverage for 
periodontal probing were ineligible for periodontal assessment. 
Examiners assessed probing depth (PD) and gingival reces-
sion at six sites per tooth (distal-facial, midfacial, mesial-facial, 
mesial-lingual, midlingual, and distal-lingual) for each fully 
erupted tooth present, except third molars. These parameters 
were used to calculate the clinical attachment level (CAL), 
which is the measure of loss of attachment from the tooth 
root surface and a marker of the extent of connective tissue 
destruction. Examiners at each site were calibrated for peri-
odontal assessments so that measurements were comparable 
and were recalibrated together each year (2008–2010) against 
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a gold standard referent who had participated in NHANES ex-
aminations. The mean interclass correlation coefficient (ICC), 
percent agreement, and Kappa statistic for periodontal pocket 
depth (PD) measures within 1 mm across all examiners were 
0.95, 95.8, and 0.94, respectively and ranged from 0.90–0.96, 
92.1–96.7, and 0.88–0.96, respectively between each exam-
iner and the reference. The mean ICC, percent agreement, and 
kappa for clinical attachment level (CAL) within 1mm across 
all examiners were 0.86, 92.8, and 0.84, respectively and 
ranged from 0.56–0.93, 84.3–98.2 and 0.88–0.96, respectively 
between each examiner and the referent.
Severe periodontitis was defined according to the classifica-
tion developed by CDC-AAP.10 It defines severe periodontitis 
as two or more interproximal sites with clinical attachment 
loss ≥ 6 mm (not on same tooth) and ≥ 1 interproximal site 
with pocket depth ≥ 5 mm. We also examined other definitions 
of periodontitis including mild and moderate levels of disease, 
extent scores, attachment loss, and probing pocket depth with 
and without bleeding. In all analyses the strength and direc-
tion of the relationships were very similar, irrespective of the 
choice of outcome and irrespective of whether it was measured 
on a continuous, ordinal, or binary scale. This consistency sup-
ports the validity of our findings.
Sleep Disordered Breathing
The protocol for evaluating SDB in the HCHS/SOL is de-
scribed elsewhere.29 Briefly, participants were instructed in the 
use of the home sleep testing monitor—Apnea Risk Evaluation 
System (ARES Unicorder 5.2; B-Alert, Carlsbad, CA)—which 
they wore unsupervised for a single in-home overnight sleep 
test. This device is a limited-channel portable sleep monitoring 
device for evaluation of SDB. It measures blood oxygen satura-
tion (SpO2) and pulse rate (reflectance pulse oximetry), airflow 
(by nasal cannula connected to a pressure transducer), snoring 
levels (calibrated acoustic microphone), head movement, and 
head position (accelerometers). Certified polysomnologists at 
a central reading center manually edited artifacts, identified 
periods of sleep, and annotated each respiratory event with its 
associated oxyhemoglobin desaturation. Respiratory events 
were identified as a ≥ 50% reduction in airflow lasting ≥ 10 
sec; events were further annotated based on level of desatura-
tion linked to each event. The apnea-hypopnea index (AHI) 
is the number of apneas plus hypopneas per estimated sleep 
hour. Interscorer and intrascorer reliability was excellent (AHI 
ICC = 0.99). Good agreement between the AHI measured by 
this monitor and by polysomnography (PSG) has been demon-
strated in a prior validation study (rho = 0.70, 95% confidence 
interval (CI): 0.47–0.92).30
We examined multiple SDB parameters to establish the con-
sistency of its relationship with severe periodontitis: the AHI 
with associated desaturations of greater or equal to 3% and 
4%; total time spent in apnea/hypopnea events; percent of time 
that blood oxygen saturation level was < 90% of baseline level; 
snoring at varying thresholds (> 30, > 40, > 50, > 60 decibels); 
and total time spent in loud snoring. In this analysis we report 
results using the AHI derived as the average number of apnea 
and hypopnea events with oxygen desaturations ≥ 3% per 
estimated hour of sleep. AHI severity thresholds of 0 events 
(nonapneic); 0.1–4.9 (subclinical); 5.0–14.9 (mild); and ≥ 15 
(moderate/severe) were applied, following a precedent set by 
the Wisconsin Sleep Cohort Study.31,32 Because only 4.1% of 
participants had ≥ 30 events per hour, severe SDB was not 
separately examined. We also assessed snoring sounds, clas-
sified as the percentage of time during which snoring levels 
exceeded 30 decibels (dB), divided into quartiles.
Statistical Analysis
Statistical analysis of these baseline HCHS/SOL data was 
conducted using Stata 13 SE 13.1 (StataCorp. 2013. Stata Sta-
tistical Software: Release 13. College Station, TX: StataCorp 
LP). Survey estimation took account of the complex sampling 
design. Standard descriptive analysis characterized unad-
justed associations between demographic and health charac-
teristics with SDB categories and severe chronic periodontitis. 
Age-stratified analysis investigated potential confounding 
and effect modification. Because snoring was not significantly 
associated with severe periodontitis in models adjusted for 
age, snoring was not included in multivariable models. Using 
binary logistic regression, odds ratios (ORs) for severe peri-
odontitis were modeled with their corresponding 95% con-
fidence limits (CL) across SDB severity categories reported, 
using AHI = 0.0 as the referent. Model 1 fitted categories of 
AHI, adjusted for age. Model 2 additionally adjusted for sex 
and Hispanic/Latino background to which Model 3 added es-
tablished periodontitis risk factors of smoking, diabetes, body 
mass index, and tooth loss along with hs-C-reactive protein 
as an explanatory variable. A final model added the product 
term of age*SDB categories and effect modification was de-
termined by the Wald test. Predicted probabilities for SDB 
categories at specified ages, adjusted for covariates, were 
plotted to aid interpretation.
RESULTS
Of the 16,415 study participants, 1,946 either did not com-
plete a sleep study or had insufficient sleep data for analysis. 
An additional 1,886 participants did not complete a periodontal 
assessment or were excluded from periodontal probing on 
medical grounds. An additional 114 were excluded for other 
missing data. In this analytic sample of 12,469 participants, 
weighted prevalence of severe periodontitis was 8.4%
Table 1 describes sociodemographic, behavioral, and health 
characteristics of the study target population. It is a young adult 
population, dominated by Mexican background. Lifetime non-
smokers comprised nearly two-thirds of the sample. Less than 
a quarter had a body mass index within the healthy range and 
about half the sample was prediabetic or diabetic. Table 1 also 
describes the prevalence of SDB severity categories by par-
ticipant characteristics. Approximately a quarter (24.3%) met 
minimal clinical criteria for OSA, defined as an AHI ≥ 5. In 
addition, 56.8% demonstrated subclinical disease (AHI 0.1–
4.9). Illustrating the strong age-gradient in SDB, prevalence 
of moderate/severe OSA (AHI ≥ 15) increased tenfold from 
2.5% among those aged 18–34 y to 23.0% among adults aged 
55 y or older. Prevalence of moderate/severe OSA was twice as 
high in men (13.0%) as in women (5.8%). Prevalence of SDB at 
any severity level was at least twofold greater for adults with 
snoring, diabetes, obesity, or high hs-CRP than their healthy 
counterparts.
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Table 2 depicts the relationship between participant charac-
teristics and severe periodontitis prevalence. There was a posi-
tive relationship of a higher prevalence of severe periodontitis 
prevalence with increasing SDB severity (P < 0.001 in adjusted 
Wald test for trend). Crude odds of severe periodontitis were 
approximately sevenfold higher at an AHI ≥ 15 compared with 
AHI 0.0 (OR = 6.9, 95% CL: 4.8, 10.0). Snoring frequency was 
less strongly associated with severe periodontitis than AHI 
severity. Consistent with a well-established literature, severe 
periodontitis prevalence was associated with male sex, older 
age, diabetes and obesity, less tooth retention, and elevated C-
reactive protein.
We investigated the presence of effect modification by sex 
and age. There was a significant effect modification by age 
(P < 0.001 for effect modification) (Table 3). The SDB and peri-
odontitis relationship was strongest in the youngest stratum, 
Table 1—Relationship between sleep disordered breathing categories and demographic and health-related characteristics in the Hispanic Community 
Health Study/Study of Latinos, United States 2008–2011 (n = 12,469).
Unweighted N
(Weighted col %)









Total 12,469 (100.0) 18.9 (17.8, 20.1) 56.8 (55.6, 58.1) 15.0 (14.1, 15.9) 9.3 (8.5, 10.1)
Age group (y)
18–34 3,005 (40.7) 32.5 (30.2, 34.8) 59.5 (57.2, 61.8) 5.6 (4.8, 6.6) 2.5 (1.9, 3.2)
35–44 2,369 (22.2) 15.3 (13.4, 17.4) 62.1 (59.6, 64.6) 14.7 (12.9, 16.7) 7.9 (6.5, 9.6)
45–54 3,828 (19.1) 9.0 (7.6, 10.5) 56.0 (53.8, 58.1) 22.7 (20.6, 25.0) 12.4 (10.9, 13.9)
≥ 55 3,267 (18.0) 3.5 (2.7, 4.4) 45.2 (42.4, 48.0) 28.4 (25.9, 30.9) 23.0 (20.5, 25.8)
Sex
Female 7,473 (52.3) 24.1 (22.3, 25.9) 58.2 (56.3, 60.0) 12.0 (11.0, 13.0) 5.8 (5.0, 6.8)
Male 4,996 (47.8) 13.3 (12.0, 14.8) 55.4 (53.4, 57.3) 18.3 (16.9, 19.7) 13.0 (11.8, 14.4)
Hispanic/Latino heritage
Dominican 1,083 (9.8) 18.2 (14.9, 22.1) 61.3 (57.0, 65.4) 12.7 (10.6, 15.1) 7.8 (5.9, 10.4)
Central American 1,303 (7.3) 19.0 (16.5, 21.9) 59.1 (55.5, 62.5) 14.1 (11.9, 16.6) 7.8 (6.2, 9.8)
Cuban 1,540 (17.7) 15.5 (13.2, 18.0) 53.8 (51.0, 56.6) 17.9 (16.1, 19.9) 12.8 (10.7, 15.4)
Mexican 5,581 (42.7) 19.6 (17.7, 21.7) 58.0 (56.1, 59.9) 14.2 (12.8, 15.6) 8.2 (7.1, 9.5)
Puerto Rican 1,784 (13.9) 17.9 (15.1, 21.0) 55.2 (51.8, 58.5) 16.2 (14.2, 18.4) 10.8 (8.5, 13.5)
South American 821 (4.9) 19.7 (15.8, 24.2) 57.4 (52.9, 61.7) 15.3 (12.5, 18.6) 7.7 (5.8, 10.1)
Other /> 1 heritage 357 (3.7) 32.0 (25.1, 39.8) 47.2 (40.2, 54.4) 13.5 (9.6, 18.7) 7.3 (4.8, 10.9)
Smoking status
Lifetime nonsmoker 7,873 (64.1) 21.1 (19.7, 22.6) 57.8 (56.2, 59.4) 13.3 (12.3, 14.4) 7.8 (6.9, 8.8)
Former smoker 2,462 (16.9) 11.1 (9.2, 13.4) 52.2 (49.4, 55.0) 21.1 (19.0, 23.4) 15.6 (13.8, 17.6)
Current smoker 2,134 (18.9) 18.5 (16.0, 21.3) 57.5 (54.6, 60.4) 15.4 (13.4, 17.6) 8.6 (7.3, 10.1)
Diabetes status
Nondiabetes 5,353 (50.7) 26.4 (24.8, 28.2) 61.1 (59.4, 62.8) 9.0 (8.1, 9.9) 3.5 (2.9, 4.2)
Prediabetes 4,777 (35.3) 12.6 (10.8, 14.6) 56.0 (53.9, 58.2) 18.7 (17.1, 20.3) 12.7 (11.2, 14.4)
Diabetes 2,339 (14.0) 7.8 (5.9, 10.2) 43.3 (40.4, 46.3) 27.4 (24.7, 30.2) 21.5 (18.9, 24.5)
Body mass index 
Underweight/healthy 2,522 (23.2) 34.8 (32.1, 37.5) 58.6 (55.8, 61.3) 5.4 (4.5, 6.5) 1.2 (0.8, 1.8)
Overweight 4,763 (37.8) 18.4 (16.8, 20.2) 60.8 (58.9, 62.7) 14.6 (13.3, 15.9) 6.2 (5.3, 7.3)
Obese 5,184 (39.0) 10.0 (8.7, 11.5) 51.9 (49.8, 54.0) 21.1 (19.6, 22.8) 17.0 (15.4, 18.7)
Number of teeth
< 20 2,134 (12.7) 6.8 (5.0, 9.0) 50.8 (47.9, 53.8) 25.9 (23.5, 28.5) 16.5 (13.7, 19.7)
20–24 3,033 (20.0) 14.5 (12.5, 16.8) 55.1 (52.5, 57.7) 17.9 (16.1, 19.8) 12.6 (10.8, 14.6)
25–26 2,323 (17.6) 16.1 (14.1, 18.5) 59.3 (56.3, 62.2) 15.8 (13.8, 18.0) 8.8 (7.3, 10.5)
27–28 4,979 (49.8) 24.8 (22.9, 26.8) 58.2 (56.2, 60.1) 10.8 (9.7, 12.0) 6.3 (5.4, 7.3)
hs-CRP (mg/L)
Low (< 1.0) 3,316 (29.9) 27.4 (25.1, 29.8) 59.2 (56.8, 61.7) 9.3 (8.1, 10.6) 4.1 (3.2, 5.1)
Intermediate (1.0–3.0) 4,615 (35.5) 17.1 (15.5, 18.9) 57.2 (55.1, 59.3) 16.2 (14.8, 17.7) 9.5 (8.4, 10.7)
High (> 3.0) 4,538 (34.6) 13.4 (11.6, 15.5) 54.3 (52.1, 56.5) 18.7 (17.2, 20.3) 13.6 (12.0, 15.2)
Time snoring > 30 dB (%)
Quartile 1 2,701 (25.0) 38.9 (36.1, 41.8) 58.2 (55.3, 61.0) 2.3 (1.8, 3.0) 0.6 (0.3, 1.0)
Quartile 2 2,978 (25.0) 19.9 (17.6, 22.4) 68.2 (65.6, 70.8) 9.5 (8.1, 11.1) 2.4 (1.8, 3.2)
Quartile 2 3,264 (25.0) 11.4 (9.9, 13.2) 62.2 (59.8, 64.6) 17.1 (15.4, 19.0) 9.2 (8.0, 10.6)
Quartile 4 3,526 (25.0) 5.5 (4.3, 6.9) 38.6 (36.2, 41.1) 31.0 (28.9, 33.2) 25.0 (22.7, 27.4)
CL, confidence limit; hs-CRP, high-sensitivity C-reactive protein.
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aged 18–34 y, among whom severe periodontitis prevalence 
increased 11-fold from AHI 0.0 (0.5%) to AHI ≥ 15 (5.8%). 
There was no apparent relationship between SDB and severe 
periodontitis prevalence above the age of 55 y.
In multivariable analysis for all 12,469 subjects (Table 4), 
Model 1 estimated odds ratios of severe periodontitis for SDB 
severity categories, using AHI 0.0 as the referent, with adjust-
ment for age. In the fully adjusted model (Model 3) periodon-
titis prevalence reached a plateau at mild SDB. hs-C reactive 
protein did not significantly attenuate the strength of associa-
tion with SDB. Compared with the nonapneic referent, adjusted 
odds of severe periodontitis were 40% higher with subclinical 
SDB (OR = 1.4, 95% CL: 1.0, 1.9), 60% higher with mild SDB 
(OR = 1.6, 95% CL: 1.1, 2.2), and 50% higher with moderate/
severe SDB (OR = 1.5, 95% CL: 1.0, 2.3) demonstrating an in-
dependent association between SDB and severe periodontitis. 
We added an interaction term of age in years and SDB catego-
ries to the fully adjusted multivariable model. The predicted 
mean probabilities of severe periodontitis depicted at specified 
ages are plotted in Figure 1. Up to the age of 50 y probability 
of severe periodontitis increased with increasing SDB severity, 




In this large population-based cohort of Hispanic/Latino 
adults, disordered breathing during sleep was positively and 
significantly associated with severe periodontitis. The relation-
ship was most pronounced at mild levels of SDB severity and 
was strongest in younger adults. Findings were consistent for 
men and women and across the major Hispanic/Latino back-
ground subgroups. The relationship was independent of tooth 
loss and established risk factors for periodontitis including 
age, male sex, smoking, diabetes, and obesity. Contrary to ex-
pectation, hs-CRP did not explain this relationship. Following 
adjustment for confounding, the SDB and periodontitis rela-
tionship remained statistically significant, but was attenuated 
in strength slightly. Any elevation in AHI above zero was as-
sociated with an approximate 50% increase in odds of severe 
periodontitis, irrespective of SDB severity.
Comparison with Published Findings
The co-occurrence of these two diseases was first reported 
in treatment-naïve OSA patients diagnosed by PSG. Among 
those patients, prevalence of examiner-verified periodontitis 
was foldfour higher than expected based on estimates obtained 
in a recent national survey.12 Even allowing for selection bias, 
small sample size and use of historical controls, an effect size 
of this magnitude is highly suggestive of a true association. A 
subsequent much larger study (n = 29,284) confirmed this re-
lationship, albeit with a smaller effect size. However that study 
drew subjects from an administrative database without stan-
dardized measurement protocols and with no adjustment for 
confounding.14 Misclassification bias was a limitation of that 
study as it was in a smaller case control study that relied on the 
four-item STOP (snoring, daytime tiredness, observed apnea, 
and high blood pressure) questionnaire to define OSA.14 The 
Table 2—Unadjusted associations of demographic and health-related 
characteristics with prevalence (%) of severe periodontitis and odds 
ratios (95% confidence limits) for severe periodontitis, Hispanic 








Sleep disordered breathing (AHI events/h)
0.0 2.8 Referent
0.1–4.9 7.4 2.8 (2.0, 3.8)
5.0–14.9 14.2 5.7 (4.1, 7.9)
≥ 15.0 16.8 6.9 (4.8, 10.0)
Time snoring > 30 dB (%)
Quartile 1 4.4 Referent
Quartile 2 7.2 1.7 (1.3, 2.2)
Quartile 2 10.6 2.6 (2.0, 3.3)
Quartile 4 11.6 2.8 (2.2, 3.7)
Age group (y)
18–34 1.2 Referent
35–44 7.6 6.8 (4.5, 10.3)
45–54 15.4 14.9 (10.2, 21.7)
≥ 55 18.3 18.3 (12.7, 26.4)
Sex
Female 6.4 Referent
Male 10.7 1.8 (1.5, 2.1)
Hispanic/Latino heritage
Dominican 6.2 0.8 (0.6, 1.1)
Central American 7.3 1.0 (0.8, 1.3)
Cuban 11.1 1.6 (1.2, 2.0)
Mexican 7.4 Referent
Puerto Rican 11.5 1.6 (1.3, 2.1)
South American 8.2 1.1 (0.8, 1.6)
Other /> 1 heritage 4.3 0.6 (0.3, 0.9)
Smoking status
Lifetime nonsmoker 6.8 Referent
Former smoker 12.2 1.9 (1.6, 2.3)
Current smoker 10.8 1.7 (1.4, 2.0)
Diabetes status
Nondiabetes 4.7 Referent
Prediabetes 10.7 2.4 (1.9, 3.0)
Diabetes 16.3 4.0 (3.2, 4.9)
Body mass index (kg/m2)
Underweight/healthy 6.0 Referent
Overweight 9.0 1.5 (1.2, 2.0)
Obese 9.3 1.6 (1.3, 2.0)
Number of retained teeth
< 20 17.4 5.6 (4.4, 7.0)
20–24 13.9 4.3 (3.4, 5.4)
25–26 9.3 2.7 (2.1, 3.5)
27–28 3.6 Referent
hs-CRP (mg/L)
Low (< 1.0) 6.4 Referent
Intermediate (1.0–3.0) 9.2 1.5 (1.2, 1.9)
High (> 3.0) 9.4 1.5 (1.2, 1.8)
AHI, apnea-hypopnea index; CL, confidence limit; hs-CRP, high-
sensitivity C-reactive protein.
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STOP was developed to screen surgical patients. Its high rate of 
false positives is acceptable in the surgical context, but for epi-
demiologic purposes, misclassification bias from measurement 
error jeopardizes the validity of findings. To our knowledge, 
there has been only one community-based study examining 
the association between periodontitis and OSA. That Korean 
study (n = 687) showed that in adults in whom OSA was di-
agnosed by PSG (AHI ≥ 5) had greater than twice the odds of 
chronic periodontitis than healthy controls, but the association 
only found in adults aged 55 y or older (adjusted OR = 2.51; 
95% CI: 1.37, 4.62) and was not found in younger adults (ad-
justed OR = 1.46; 95% CI: 0.80, 2.68).33 However, because the 
youngest adults in that study were 47 y of age, it was not pos-
sible to compare effects in young adults.
Consideration of Possible Mechanisms
Several pathophysiological mechanisms may contribute to 
the relationship between SDB and severe periodontitis. Be-
cause both diseases are associated with systemic inflamma-
tion, it is plausible that periodontitis mediates the activation 
of inflammatory pathways in SDB or vice versa. Although 
this study found that hs-CRP was elevated in SDB and peri-
odontitis, the fact that CRP did not attenuate the strength of 
association between SDB and periodontitis suggests that CRP 
Table 3—Prevalence (%) of severe chronic periodontitis (95% confidence limits) according to sleep disordered breathing, stratified by age group in the 
Hispanic Community Health Study/Study of Latinos, United States 2008–2011 (n = 12,469).
18–34 y
(n = 3,005) P
35–44 y
(n = 2,369) P
45–54 y
(n = 3,828) P
 ≥ 55 y
(n = 3,267) P
Total, % (95% CL) 1.2 (0.9, 1.7) 7.6 (6.3, 9.3) 15.4 (13.7, 17.3) 18.3 (16.5, 20.3)
SDB (AHI events per hour) 
0.0 0.5 (0.2, 1.1)  < 0.001 5.1 (3.1, 8.2) 0.334 10.6 (6.9, 15.9) 0.002 19.6 (10.1, 34.8) 0.463
0.1–4.9 1.4 (0.9, 2.2) 7.9 (6.2, 10.0) 13.4 (11.4, 15.7) 16.7 (14.2, 19.5)
5.0–14.9 1.2 (0.4, 3.3) 9.2 (6.0, 14.0) 19.2 (15.2, 23.9) 18.8 (15.6, 22.3)
 ≥ 15.0 5.8 (1.9, 16.1) 7.7 (4.2, 13.7) 21.1 (16.3, 26.9) 20.8 (16.4, 26.0)
AHI, apnea-hypopnea index; CL, confidence limit; SDB, sleep disordered breathing.
Table 4—Odds of severe periodontitis (95% confidence limits) according to sleep disordered breathing severity, Hispanic Community Health Study/Study 
of Latinos, United States 2008–2011 (n = 12,469).
 Model 1 P Model 2 P  Model 3 P 
Intercept 0.0 (0.0, 0.0)  < 0.001 0.0 (0.0, 0.0)  < 0.001 0.0 (0.0, 0.0)  < 0.001
SDB (AHI events per hour) (ref: 0.0)
0.1–4.9 1.7 (1.2, 2.3) 0.002 1.5 (1.1, 2.0) 0.021 1.4 (1.0, 1.9) 0.028
5.0–14.9 2.1 (1.5, 2.9)  < 0.001 1.7 (1.2, 2.4) 0.005 1.6 (1.1, 2.2) 0.015
≥ 15.0 2.2 (1.5, 3.3)  < 0.001 1.6 (1.1, 2.4) 0.020 1.5 (1.0, 2.3) 0.045
Age in years estimated per decade 1.8 (1.7, 1.9)  < 0.001 1.8 (1.7, 1.9)  < 0.001 1.8 (1.7, 2.0)  < 0.001
Male sex (ref: female) 2.0 (1.7, 2.3)  < 0.001 1.9 (1.6, 2.2)  < 0.001
Hispanic/Latino heritage (ref: Mexican)
Dominican 0.8 (0.6, 1.1) 0.138 0.8 (0.6, 1.1) 0.247
Central American 0.9 (0.7, 1.2) 0.616 1.0 (0.7, 1.3) 0.833
Cuban 1.0 (0.8, 1.3) 0.975 1.0 (0.8, 1.3) 0.981
Puerto Rican 1.2 (1.0, 1.6) 0.101 1.2 (0.9, 1.6) 0.207
South American 0.9 (0.6, 1.3) 0.602 1.0 (0.7, 1.4) 0.793
More than one heritage/other 0.7 (0.4, 1.2) 0.173 0.7 (0.4, 1.2) 0.170
Number of retained teeth 1.0 (1.0, 1.0) 0.737
Smoking status (ref: Lifetime nonsmoker)
Former smoker 1.1 (0.9, 1.4) 0.225
Current smoker 1.7 (1.3, 2.1)  < 0.001
Diabetes status (ref: nondiabetes]
Prediabetes 1.3 (1.0, 1.6) 0.066
Diabetes 1.4 (1.1, 1.9) 0.014
Body mass index 1.0 (1.0, 1.0) 0.718
hs-CRP 1.0 (1.0, 1.0) 0.614
Model 1 reports main effects of sleep-disordered breathing with adjustment for age per decade of age (age in years divided by 10). Model 2 additionally 
adjusts for sex and heritage. Model 3 additionally adjusts for number of teeth, smoking, diabetes status, body mass index, and high sensitivity C-reactive 
protein (hs-CRP). AHI, apnea-hypopnea index; SDB, sleep disordered breathing.
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is an unlikely mediator of this relationship. Other inflamma-
tory proteins common to both conditions should be explored 
including interleukin-6 and soluble intercellular adhesion mol-
ecule 1.34–36
Another potential mechanism is the side effects of pre-
scription medications. Medications for hypertension such as 
diuretics and alpha and beta blockers are common causes 
of decreased salivary flow. Drugs such as calcium channel 
blockers, phenytoins, and cyclosporine induce an overgrowth 
of gingival tissue. However, this relationship requires careful 
consideration. Periodontal diseases encompass a broad spec-
trum of diseases ranging in severity from gingivitis to severe 
periodontitis. Although hyposalivation is an established risk 
factor for dental caries and a recognized cause of gingival 
inflammation, neither hyposalivation nor gingival inflam-
mation are risk factors for periodontitis. Moreover, gingival 
overgrowth does not initiate periodontal loss of attachment or 
promote periodontal destruction. Two reviews have examined 
the literature on the relationship between medication and peri-
odontal diseases. These reviews find that although some drugs 
increase gingival inflammation, medication has minimal ef-
fect on the much more serious condition of periodontitis. In 
fact, immunosuppressants, nonsteroidal anti-inflammatory 
drugs, and cyclooxygenase-2 inhibitors tend to dampen down 
inflammatory reactions and protect against destructive loss 
of alveolar bone.37,38 Although an investigation of the effect 
of medication on this relationship is beyond the scope of this 
analysis, the topic warrants further exploration in future 
studies.
A third mechanism could be related to intermittent hypoxia. 
A hallmark of periodontitis is irreversible and accumulative de-
struction of alveolar bone. An interesting finding in one study 
was that chronic intermittent hypoxia may stimulate bone re-
modeling, preserving bone density in elderly adults39 and in 
laboratory rats under experimental conditions.40 Although 
speculative, it is possible that a protective effect of hypoxia 
against bone loss is one reason for the muted relationship of 
SDB and periodontitis among older adults. A less speculative 
explanation involves patterns of age-specific prevalence and 
severity of OSA; prevalence tends to increase to around age 55 
y and then plateau, whereas OSA severity peaks at around age 
55 y and then decreases.41
Strengths of the Study
The HCHS/SOL is the first large-scale community-based 
study to examine the relationship between SDB and periodon-
titis. It is also the first to examine this relationship in a Hispanic/
Latino population where associations may differ from those in 
other populations such as the Asian population studied in the 
Korean Genome and Epidemiology Study. The 2010 National 
Health Interview Survey noted marked differences in health 
and risk factor profiles between Hispanic and non-Hispanic 
white populations. Age-adjusted estimates show higher preva-
lence of obesity and greater probability of lifetime nonsmoking 
Figure 1—Relationship of sleep disordered breathing (SDB) severity, assessed by the apnea-hypopnea index and chronic severe periodontitis (n = 
12,469). Estimates are expressed at specified ages of 20, 25, 30, 35, 40, 45, 50, 55, and 60 y, stratified at severity thresholds. Predicted estimates were 
obtained from a binary logistic regression model that adjusted for age, sex, and heritage, number of retained teeth, smoking, diabetes, body mass index, 
and high-sensitivity C-reactive protein. Findings show a monotonic relationship of greater probability of severe periodontitis at greater SDB severity. There 
is an effect modification of age (P < 0.001) such that SDB has a stronger relationship with severe periodontitis in younger adults and that this relationship 
weakens at older ages. AHI, apnea-hypopnea index; CI, confidence interval.
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in Mexican Americans than non-Hispanic whites. In addition, 
Hispanic had higher rates of diabetes and lower rates of asthma 
and other respiratory disorders. Cancer, rather than heart dis-
ease, was the main cause of death in Hispanics. Because obe-
sity is associated with both SDB and periodontitis and because 
smoking and diabetes are causally implicated in periodontitis, 
findings in this Hispanic/Latino population may differ from 
similar studies conducted in the majority white population.42
The use of rigorous established protocols permitted ob-
jective assessments of the relationship between SDB and se-
vere periodontitis. Being population-based, findings are free 
of clinical selection biases. Moreover, because of probability 
sampling, findings are generalizable beyond the selected 
sample to the urban-dwelling Hispanic/Latino population in 
these geographical regions. Unlike prior research, as in the 
Korean Genome and Epidemiology Study,33 the HCHS/SOL 
recruited Hispanic/Latino adults over a wide age distribution, 
shedding light on health issues in a growing segment of the 
US population. This analysis of baseline data was by neces-
sity cross-sectional, as such, the study design limits the ability 
to establish temporal sequence or causal inference. We expect 
that SDB increases risk for periodontitis, but the relationship 
could be bidirectional or it could be that periodontitis influ-
ences sleep breathing.
Limitations
Prescribed drugs are important in the management of SDB. 
If medications for SDB are also associated with periodontitis, 
then potential for confounding exists. A limitation of this 
study is that it did not take account of prescribed medication. 
Likewise, findings must be interpreted in light of the limita-
tion that analysis did not account for potential confounding 
of alcohol consumption. Evidence of an independent effect of 
alcohol on periodontitis is weak and longitudinal studies are 
lacking at this time.43 Yet, if alcohol consumption is greater in 
some groups than others, its omission from analytic models 
could either overestimate or underestimate the true association 
between SDB and periodontitis. The failure to adjust for un-
known and unmeasured confounders limits the ability of these 
regression models to fully account for their separate and joint 
effects and will result in residual confounding.
Irrespective of whether SDB influences periodontitis or is a 
consequence of it, even if a small percentage of one disorder is 
attributable to the other, the public health significance is con-
siderable, given the high population prevalence of both disor-
ders. Only 1.3% of adults with OSA in this cohort reported a 
clinical diagnosis of OSA.29 Future follow-up of the cohort will 
allow investigators to observe the natural history of SDB and 
build on to these findings.
Screening for undiagnosed SDB in dental settings may be 
a valuable public health strategy. Dental personnel already 
conduct limited screening for chronic conditions such as hy-
pertension and diabetes – medical disorders that have been 
associated with untreated SDB. Like these conditions, SDB 
is common and screening is easy to administer through ques-
tionnaires and clinical examination for skeletal and soft-tissue 
characteristics that have been linked to SDB.
It is possible that treatment of SDB would improve the 
health of the periodontium in patients with periodontitis or the 
response of the patients to periodontal therapy. Because both 
periodontitis and the use of oral appliances for the treatment 
of SDB are under the purview of dentists, future studies might 
determine whether oral appliance therapy has a therapeutic 
benefit on periodontal parameters.
CONCLUSION
This study identified a novel association between mild 
SDB and periodontitis in young adults. Long-term trials with 
continuous positive airway pressure could consider including 
change in periodontitis as a potential secondary outcome.
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